REG - Intnl. Biotechnology - Dividend Declaration

International Biotechnology TrustAnnouncement

22/07/2022 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220722:nRSV5013Ta&default-theme=true

RNS Number : 5013T  Intl. Biotechnology Trust PLC  22 July 2022

22 July 2022

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

(the "Company")

 

Dividend Declaration

 

At the Annual General Meeting held on 8 December 2021, Shareholders approved
the

Company's dividend policy of making dividend payments, equivalent to 4 per
cent. of the Company's Net Asset Value as at the last day of the preceding
financial year (31 August), through two equal semi-annual distributions. In
accordance with this policy, the first Interim Dividend for the period ending
31 August 2022 was paid in January 2022.

 

The Directors have today declared the second Interim Dividend for the period
ending 31

August 2022 of 15.7p per Ordinary Share.

 

The second Interim Dividend will be payable on Friday, 26 August 2022 to
holders of Ordinary Shares on the Register at the close of business on Friday,
5 August 2022 (ex-dividend Shares on the Register at Thursday, 4 August 2022).

 

For further information contact:

 

Company Secretary - Link Company Matters

 

Chris John                +44 (0) 333 300 1950

 

LEI: 213800N1QUJ744P76D11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVRTMITMTTTBLT